|
DNAJC9 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.152210E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.297500E-02 |
| Normal-vs-Stage2 |
1.115420E-01 |
| Normal-vs-Stage3 |
5.821600E-02 |
| Normal-vs-Stage4 |
4.416600E-01 |
| Stage1-vs-Stage2 |
1.383840E-03 |
| Stage1-vs-Stage3 |
7.665800E-01 |
| Stage1-vs-Stage4 |
5.003200E-01 |
| Stage2-vs-Stage3 |
1.844480E-03 |
| Stage2-vs-Stage4 |
3.864500E-02 |
| Stage3-vs-Stage4 |
4.048400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.336400E-02 |
| Normal-vs-AfricanAmerican |
9.604000E-02 |
| Normal-vs-Asian |
4.034300E-02 |
| Caucasian-vs-AfricanAmerican |
6.220800E-01 |
| Caucasian-vs-Asian |
2.484200E-01 |
| AfricanAmerican-vs-Asian |
7.521800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.004200E-01 |
| Normal-vs-Female |
1.002970E-01 |
| Male-vs-Female |
6.163000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.647800E-02 |
| Normal-vs-Age(41-60Yrs) |
7.194600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.096000E-01 |
| Normal-vs-Age(81-100Yrs) |
5.447700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.766400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.779000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.176000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.301600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.706630E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.796200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.209400E-01 |
| Classical-VS-Follicular |
1.3035999946176E-08 |
| Classical-VS-Other |
4.434200E-01 |
| Classical-VS-Normal |
1.273630E-02 |
| Tall-VS-Follicular |
4.009800E-04 |
| Tall-VS-Other |
3.103800E-01 |
| Tall-VS-Normal |
1.352150E-02 |
| Follicular-VS-Other |
3.216000E-01 |
| Follicular-VS-Normal |
4.420100E-02 |
| Other-VS-Normal |
7.883800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.650400E-01 |
| Normal-vs-N1 |
4.490400E-01 |
| N0-vs-N1 |
9.548200E-01 |
|
|
